Tuning the In Vivo Transport of Anticancer Drugs Using Renal-Clearable Gold Nanoparticles

Chuanqi Peng1, Jing Xu1, Mengxiao Yu1

  • 1Department of Chemistry and Biochemistry, The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, TX, 75080, USA.

Insights

Renal-clearable gold nanoparticles (AuNPs) improve anticancer drug delivery by enhancing tumor targeting and accelerating drug clearance. This approach reconciles key challenges in cancer nanomedicine for better therapeutic outcomes.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Pharmacology

Background:

  • Effective cancer nanomedicines require precise control over drug delivery to both normal and cancerous tissues.
  • Understanding nanoparticle interactions is crucial for overcoming the targeting-clearance and permeation-retention paradoxes in drug delivery.

Purpose of the Study:

  • To investigate how renal-clearable gold nanoparticles (AuNPs) influence the distribution and retention of doxorubicin in cancerous and normal tissues.
  • To evaluate the potential of AuNPs in reconciling challenges in anticancer drug delivery.

Main Methods:

  • Systematic in vivo investigation of renal-clearable AuNPs.
  • Assessment of doxorubicin permeation, distribution, and retention in cancerous and normal tissues.
  • Evaluation of AuNP impact on drug targeting and body clearance.

Main Results:

  • Renal-clearable AuNPs demonstrated rapid tumor targeting and high tumor vascular permeability, similar to free drugs.
  • AuNPs accelerated the clearance of off-target doxorubicin through renal elimination.
  • Engineered nanoparticles can be utilized to manage in vivo drug transport behaviors.

Conclusions:

  • Renal-clearable AuNPs offer a promising strategy to enhance anticancer drug delivery efficacy.
  • This approach effectively addresses the targeting-clearance and permeation-retention paradoxes.
  • Nanoparticle engineering provides a versatile tool for optimizing cancer nanomedicine performance.

Related Concept Videos

Drug Elimination: Non-Renal Routes01:23

Drug Elimination: Non-Renal Routes

The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
3.2K
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
587
Renal Drug Excretion: Overview01:15

Renal Drug Excretion: Overview

As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
682
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
707
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa01:22

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
555
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
522